These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. Montastruc JL; Schmitt L; Bagheri H Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)]. Danielczyk W Aktuelle Gerontol; 1979 Sep; 9(9):427-31. PubMed ID: 44122 [TBL] [Abstract][Full Text] [Related]
30. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis. Arnold G; Trenkwalder C; Schwarz J; Oertel WH Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949 [No Abstract] [Full Text] [Related]
31. [Hypersexuality during use of levodopa]. van Deelen RA; Rommers MK; Eerenberg JG; Egberts AC Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2095-8. PubMed ID: 12448966 [TBL] [Abstract][Full Text] [Related]
32. The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. Koprich JB; Huot P; Fox SH; Jarvie K; Lang AE; Seeman P; Brotchie JM Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():151-6. PubMed ID: 23306217 [TBL] [Abstract][Full Text] [Related]
33. [Problem in prolonged levodopa administration of Parkinson disease patients--from the standpoint of the autonomic nervous function]. Matsui TA; Nishikawa S; Saigo K; Kihara M; Takahashi M Rinsho Shinkeigaku; 1998 Apr; 38(4):295-300. PubMed ID: 9742874 [TBL] [Abstract][Full Text] [Related]
34. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
35. The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches. Merims D; Ziv I; Sherki Y; Djaldetti R; Melamed E Neurol Neurochir Pol; 2001; 35 Suppl 3():65-8. PubMed ID: 12001656 [TBL] [Abstract][Full Text] [Related]
36. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease. Barbato L; Monge A; Stocchi F; Nordera G Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152 [TBL] [Abstract][Full Text] [Related]